Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 2Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Neoplasm Metastasis 6Lymphoma, Extranodal NK-T-Cell 6Carcinoma, Hepatocellular 5Stomach Neoplasms 3Nasopharyngeal Carcinoma 3Locally Advanced Rectal Cancer 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Advanced Solid Tumor 3Triple Negative Breast Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Nasopharyngeal Neoplasms 2Melanoma 2Epstein-Barr Virus Infections 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Sarcoma 1Recurrence 1Rectal Neoplasms 1Pancreatic Adenocarcinoma Metastatic 1Osteosarcoma 1Objective Response Rate 1NSCLC 1Muscle-Invasive Bladder Carcinoma 1Lymphoma, T-Cell 1Lymphoma 1Kidney Neoplasms 1Immunoblastic Lymphadenopathy 1

Interventions

Cisplatin 12Radiotherapy 6Gemcitabine 6Paclitaxel 5Fluorouracil 4Radiotherapy, Intensity-Modulated 3Docetaxel 3spartalizumab 2sintilimab 2nimotuzumab 2camrelizumab 2Surveys and Questionnaires 2Endostatins 2Carboplatin 2triethanolamine 1toripalimab 1regramostim 1fluzoparib 1fluoromisonidazole 1endostar protein 1Vitamin B 12 1Tomography, Optical Coherence 1Taxes 1Rubidium-82 1Ritonavir 1Re-Irradiation 1Procaine 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Nasopharyngeal Neoplasms × spartalizumab × Clear all
NCT03700476 2023-03-28

CONTINUUM

Sun Yat-sen University

Phase 3 Unknown
425 enrolled
Head & Neck

Nasopharyngeal Neoplasms

NCT03619824 2018-10-09

PD-1 Blockade Combined With Definitive Chemoradiation in Locoregionally-advanced Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 2 Unknown
40 enrolled
Head & Neck

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡